784 related articles for article (PubMed ID: 36200207)
1. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
2. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
3. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
4. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
5. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
6. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
7. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
Mahbub NU; Islam MM; Hong ST; Chung HJ
Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
[TBL] [Abstract][Full Text] [Related]
11. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
12. Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.
Pan I; Issac PK; Rahman MM; Guru A; Arockiaraj J
Mol Neurobiol; 2023 Oct; ():. PubMed ID: 37851313
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
14. The gut-brain axis in Parkinson's disease.
Bonaz B
Rev Neurol (Paris); 2024; 180(1-2):65-78. PubMed ID: 38129277
[TBL] [Abstract][Full Text] [Related]
15. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
16. Probiotic
Pan S; Wei H; Yuan S; Kong Y; Yang H; Zhang Y; Cui X; Chen W; Liu J; Zhang Y
Front Cell Infect Microbiol; 2022; 12():1022879. PubMed ID: 36439235
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
18. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
Dong S; Sun M; He C; Cheng H
Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
[TBL] [Abstract][Full Text] [Related]
19. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
[TBL] [Abstract][Full Text] [Related]
20. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).
Lei Q; Wu T; Wu J; Hu X; Guan Y; Wang Y; Yan J; Shi G
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
